Cargando…

The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer

SIMPLE SUMMARY: Serum levels of MGP, Gas6, vitamin K(1), and EGFR were not significantly changed in response to the first cycle of chemotherapy. We found a strong correlation between MGP and VitK(1) serum values, and a moderate negative correlation between VitK(1) and EGFR in pre-treatment patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Crintea, Andreea, Dutu, Alina Gabriela, Constantin, Anne-Marie, Fekete, Zsolt, Samasca, Gabriel, Lupan, Iulia, Florian, Ioan Alexandru, Silaghi, Ciprian Nicolae, Craciun, Alexandra Marioara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772821/
https://www.ncbi.nlm.nih.gov/pubmed/35053080
http://dx.doi.org/10.3390/biology11010082
_version_ 1784635934260592640
author Crintea, Andreea
Dutu, Alina Gabriela
Constantin, Anne-Marie
Fekete, Zsolt
Samasca, Gabriel
Lupan, Iulia
Florian, Ioan Alexandru
Silaghi, Ciprian Nicolae
Craciun, Alexandra Marioara
author_facet Crintea, Andreea
Dutu, Alina Gabriela
Constantin, Anne-Marie
Fekete, Zsolt
Samasca, Gabriel
Lupan, Iulia
Florian, Ioan Alexandru
Silaghi, Ciprian Nicolae
Craciun, Alexandra Marioara
author_sort Crintea, Andreea
collection PubMed
description SIMPLE SUMMARY: Serum levels of MGP, Gas6, vitamin K(1), and EGFR were not significantly changed in response to the first cycle of chemotherapy. We found a strong correlation between MGP and VitK(1) serum values, and a moderate negative correlation between VitK(1) and EGFR in pre-treatment patients. The post-treatment value of EGFR is a strong independent factor that correlates positively with the Gas6 post-treatment values. ABSTRACT: Background: Vitamin K-dependent proteins (VKDPs) and the epidermal growth factor receptor (EGFR) are involved in lung cancer progression. Therefore, we aimed to study the serum concentration of Matrix Gla protein (MGP), Growth Arrest-specific 6 (Gas6), and EGFR before and after the first cycle of chemotherapy and to investigate how MGP, Gas6, and EGFR are modified after one cycle of chemotherapy. Methods: We performed an observational study on twenty patients diagnosed with lung cancer, by assessing the serum concentration of vitaminK(1) (VitK(1)), MGP, Gas6, and EGFR using the ELISA technique before and after three weeks of the first cycle of chemotherapy. Patients were evaluated using RECIST 1.1 criteria. Results: Serum levels of MGP, Gas6, EGFR, and VK(1) before and after treatment were not changed significantly. Regarding the pre-treatment correlation of the MGP values, we found a strong positive relationship between MGP and VK(1) pre-treatment values (r = 0.821, 95%CI 0.523; 0.954, p < 0.001). Furthermore, there was a moderately negative correlation between VK(1) and EGFR pre-treatment values, with the relationship between them being marginally significant (r = −0.430, 95%CI −0.772; 0.001, p = 0.058). Post-treatment, we found a strong positive relationship between MGP and VK(1) post-treatment values (r = 0.758, 95%CI 0.436; 0.900, p < 0.001). We also found a moderate positive relationship between Gas6 and EGFR post-treatment values, but the correlation was only marginally significant (r = 0.442, p = 0.051).
format Online
Article
Text
id pubmed-8772821
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87728212022-01-21 The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer Crintea, Andreea Dutu, Alina Gabriela Constantin, Anne-Marie Fekete, Zsolt Samasca, Gabriel Lupan, Iulia Florian, Ioan Alexandru Silaghi, Ciprian Nicolae Craciun, Alexandra Marioara Biology (Basel) Article SIMPLE SUMMARY: Serum levels of MGP, Gas6, vitamin K(1), and EGFR were not significantly changed in response to the first cycle of chemotherapy. We found a strong correlation between MGP and VitK(1) serum values, and a moderate negative correlation between VitK(1) and EGFR in pre-treatment patients. The post-treatment value of EGFR is a strong independent factor that correlates positively with the Gas6 post-treatment values. ABSTRACT: Background: Vitamin K-dependent proteins (VKDPs) and the epidermal growth factor receptor (EGFR) are involved in lung cancer progression. Therefore, we aimed to study the serum concentration of Matrix Gla protein (MGP), Growth Arrest-specific 6 (Gas6), and EGFR before and after the first cycle of chemotherapy and to investigate how MGP, Gas6, and EGFR are modified after one cycle of chemotherapy. Methods: We performed an observational study on twenty patients diagnosed with lung cancer, by assessing the serum concentration of vitaminK(1) (VitK(1)), MGP, Gas6, and EGFR using the ELISA technique before and after three weeks of the first cycle of chemotherapy. Patients were evaluated using RECIST 1.1 criteria. Results: Serum levels of MGP, Gas6, EGFR, and VK(1) before and after treatment were not changed significantly. Regarding the pre-treatment correlation of the MGP values, we found a strong positive relationship between MGP and VK(1) pre-treatment values (r = 0.821, 95%CI 0.523; 0.954, p < 0.001). Furthermore, there was a moderately negative correlation between VK(1) and EGFR pre-treatment values, with the relationship between them being marginally significant (r = −0.430, 95%CI −0.772; 0.001, p = 0.058). Post-treatment, we found a strong positive relationship between MGP and VK(1) post-treatment values (r = 0.758, 95%CI 0.436; 0.900, p < 0.001). We also found a moderate positive relationship between Gas6 and EGFR post-treatment values, but the correlation was only marginally significant (r = 0.442, p = 0.051). MDPI 2022-01-06 /pmc/articles/PMC8772821/ /pubmed/35053080 http://dx.doi.org/10.3390/biology11010082 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Crintea, Andreea
Dutu, Alina Gabriela
Constantin, Anne-Marie
Fekete, Zsolt
Samasca, Gabriel
Lupan, Iulia
Florian, Ioan Alexandru
Silaghi, Ciprian Nicolae
Craciun, Alexandra Marioara
The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
title The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
title_full The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
title_fullStr The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
title_full_unstemmed The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
title_short The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer
title_sort first evaluation of serum levels of mgp, gas6 and egfr after first dose of chemotherapy in lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772821/
https://www.ncbi.nlm.nih.gov/pubmed/35053080
http://dx.doi.org/10.3390/biology11010082
work_keys_str_mv AT crinteaandreea thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT dutualinagabriela thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT constantinannemarie thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT feketezsolt thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT samascagabriel thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT lupaniulia thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT florianioanalexandru thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT silaghicipriannicolae thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT craciunalexandramarioara thefirstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT crinteaandreea firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT dutualinagabriela firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT constantinannemarie firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT feketezsolt firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT samascagabriel firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT lupaniulia firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT florianioanalexandru firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT silaghicipriannicolae firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer
AT craciunalexandramarioara firstevaluationofserumlevelsofmgpgas6andegfrafterfirstdoseofchemotherapyinlungcancer